These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12182113)

  • 1. A role for effectors of cellular immunity in epimorphic regeneration of amphibian limbs.
    Fahmy GH; Sicard RE
    In Vivo; 2002; 16(3):179-84. PubMed ID: 12182113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-2 does not overcome suppression of graft rejection by cyclosporin A: effect of cyclosporin A on T cell properties in vivo.
    Magae J; Matsubara H; Aotsuka N; Kurasawa K; Shearer GM
    Cell Immunol; 1996 Nov; 173(2):276-81. PubMed ID: 8912887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts.
    Huang WH; Yan Y; De Boer B; Bishop GA; House AK
    Transplantation; 2003 Feb; 75(3):368-74. PubMed ID: 12589161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A high-capacity quantitative mouse model of drug-mediated immunosuppression based on rejection of an allogeneic subcutaneous tumor.
    Hammond-McKibben D; Lake P; Zhang J; Tart-Risher N; Hugo R; Weetall M
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1144-51. PubMed ID: 11356940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of acute and chronic cardiac allograft rejection in mice by inhibition of chemokine receptor 5 in combination with cyclosporine A.
    Li J; Xia J; Zhang K; Xu L
    J Surg Res; 2009 Nov; 157(1):81-90. PubMed ID: 19577762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined donor leucocyte administration and immunosuppressive drug treatment for survival of rat heart allografts.
    den Dulk M; Wang C; Li J; Clark DA; Hibberd AD; Terpstra OT; McCaughan GW; Bishop GA
    Transpl Immunol; 2004 Nov; 13(3):177-84. PubMed ID: 15381200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel immunomodulator KRP-203 combined with cyclosporine prolonged graft survival and abrogated transplant vasculopathy in rat heart allografts.
    Takahashi M; Shimizu H; Murakami T; Enosawa S; Suzuki C; Takeno Y; Hakamata Y; Kudou S; Izawa S; Yasue T; Kobayashi E
    Transplant Proc; 2005; 37(1):143-5. PubMed ID: 15808575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of MD-1 expression by immunosuppressants or antisense oligodeoxynucleotides on skin allograft survival in mice.
    Zhang X; Chen BC; Xiang FL; Chang S; Zhou HM; Du DF; Yuan J; Chen ZK
    Transplant Proc; 2005 May; 37(4):1965-7. PubMed ID: 15919519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of cyclosporin A on lymphocyte attenuator expression.
    Zeng C; Zhen Y; Shu SA; Wu T; Yi H; Lian ZX; Zhao Y
    J Autoimmun; 2007 Jun; 28(4):234-44. PubMed ID: 17449225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of A2A adenosine receptor agonist on composite tissue allotransplant survival: an in vivo preliminary study.
    Ulusal BG; Ulusal AE; Hung LM; Wei FC
    J Surg Res; 2006 Apr; 131(2):261-6. PubMed ID: 16457843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early up-regulation of CXC-chemokine expression is associated with strong cellular immune responses to murine skin xenografts.
    Lee EM; Park JO; Kim D; Kim JY; Oh KH; Park CG; Oh BH; Kim S; Ahn C
    Xenotransplantation; 2006 Jul; 13(4):328-36. PubMed ID: 16768726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-BETA expression.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Transplant Proc; 2006 Dec; 38(10):3239-40. PubMed ID: 17175234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
    Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
    Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-specific immunosuppression: mechanisms of cellular immunosuppression that are operative at local and systemic levels.
    Patam MA; Tran HS; Llull R; Chrzanowski FA; Black KS; Hewitt CW
    J Burn Care Rehabil; 2000; 21(1 Pt 1):10-9. PubMed ID: 10661533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sinomenine blocks tissue remodeling in a rat model of chronic cardiac allograft rejection.
    Mark W; Schneeberger S; Seiler R; Stroka DM; Amberger A; Offner F; Candinas D; Margreiter R
    Transplantation; 2003 Apr; 75(7):940-5. PubMed ID: 12698077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FTY720 in combination with cyclosporine--an analysis of skin allograft survival and renal function.
    Silva FR; Silva LB; Cury PM; Burdmann EA; Bueno V
    Int Immunopharmacol; 2006 Dec; 6(13-14):1911-8. PubMed ID: 17161344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C inhibitor, AEB-071, acts complementarily with cyclosporine to prevent islet rejection in rats.
    Merani S; Pawlick RL; Edgar RL; Toso C; Emamaullee J; Anderson CC; Shapiro AM
    Transplantation; 2009 Jan; 87(1):59-65. PubMed ID: 19136892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine A inhibits lymphocyte migration into ovine peripheral nerve allografts.
    Hare GM; Mackinnon SE; Midha R; Wong PY; Au B; Munro C; Andrade W; Hunter DA; Hay JB
    Microsurgery; 1996; 17(12):697-705. PubMed ID: 9588715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of donor bone marrow mesenchymal stem cells for treatment of skin allograft rejection in a preclinical rat model.
    Sbano P; Cuccia A; Mazzanti B; Urbani S; Giusti B; Lapini I; Rossi L; Abbate R; Marseglia G; Nannetti G; Torricelli F; Miracco C; Bosi A; Fimiani M; Saccardi R
    Arch Dermatol Res; 2008 Mar; 300(3):115-24. PubMed ID: 18259766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.